KPKamalendu Pal

Kamalendu Pal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kamalendu Pal has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Structural underpinnings of human Slo1 inhibition by scorpion and fungal toxins

    by Gopal S. Kallure, Kamalendu Pal, Gabriel W. Prather, Sandipan Chowdhury

    Slo1 channels regulate key electrochemical signaling events in a variety of excitable and nonexcitable cells. Here, we have investigated the mechanisms by which distinct small molecules inhibit human Slo1 (hSlo1) channel activity using single-particle cryo-EM, liposome flux, and toxin-binding assays. We find that unlike classical permeation blockers like scorpion toxins, indole diterpene (ID) class of fungal mycotoxins, paxilline and penitrem A, are ensconced in a binding pocket, deep within the putatively closed hSlo1 pore and sterically restrict its opening. Binding of paxilline to its gating inhibition site dramatically slows dissociation of a fluorescent charybdotoxin derivative, via an allosteric mechanism that likely involves a key residue on the S5 helix (W246). Although four paxilline molecules may concurrently engage the hSlo1 pore, binding of <4 molecules is sufficient for efficacious inhibition of channel opening but inefficient at arresting toxin dissociation. We also find evidence that under divalent and ID free conditions, the ID binding pocket of hSlo1 is occluded by lipids that extend into the hSlo1 pore lumen through interhelical crevices that become constricted in the divalent bound open state. These lipids may not only competitively regulate ID binding but also tune the energetics of channel gating, sterically or by altering the hydration state of the pore vestibule. Our study provides a framework to understand fundamental Slo1 gating mechanisms and aid future developments of therapeutically beneficial small molecule Slo1 inhibitors.

  • Open Access

    Structures of c-di-GMP/cGAMP degrading phosphodiesterase VcEAL: identification of a novel conformational switch and its implication

    by Malti Yadav, Kamalendu Pal, Udayaditya Sen

    Cyclic dinucleotides (CDNs) have emerged as the central molecules that aid bacteria to adapt and thrive in changing environmental conditions. Therefore, tight regulation of intracellular CDN concentration by counteracting action of dinucleotide cyclases (DNCs) and phosphodiesterases (PDEs) is critical. Here we demonstrate that a putative standalone EAL domain PDE from Vibrio cholerae (VcEAL) is capable to degrade both the second messenger c-di-GMP and hybrid 3′, 3′-cyclic GMP-AMP (cGAMP). To unveil their degradation mechanism, we have determined high resolution crystal structures of VcEAL with Ca2+, c-di-GMP-Ca2+, 5'pGpG-Ca2+ and cGAMP-Ca2+, the latter provides the first structural basis of cGAMP hydrolysis. Structural studies reveal a typical TIM-barrel-fold with substrate c-di-GMP/cGAMP bound in an extended conformation. Highly conserved residues specifically bind the guanine base of c-di-GMP/cGAMP in G2 site while semi-conserved nature of residues at G1 site could act as specificity determinant. Two metal ions, coordinated with six stubbornly conserved residues and two non-bridging scissile phosphate oxygens of c-di-GMP/cGAMP, activate a water molecule for in-line attack on the phosphodiester bond, supporting two-metal-ion based catalytic mechanism. PDE activity and biofilm assays of several prudently designed mutants collectively demonstrate that VcEAL active site is charge and size optimised. Intriguingly, in VcEAL-5'pGpG-Ca2+ structure, b5-a5loop adopts a novel conformation that alongwith conserved E131 creates a new metal binding site. This novel conformation alongwith several subtle changes in active site designate VcEAL-5'pGpG-Ca2+ structure is quite different from other 5'pGpG bound structures reported earlier.